Subacute Prurigo or Bullous Pemphigoid: Diagnostic Challenges Arising From Narrowband UVB Therapy
BACKGROUND: Phototherapy is widely used in dermatology and is generally safe, but it may occasionally trigger other dermatoses, including immune-mediated bullous diseases. Bullous pemphigoid (BP) is characterized by subepidermal blisters and autoantibodies against hemidesmosomal antigens and is diagnosed by histopathology and immunofluorescence. BP often has a prolonged prodromal phase with pruritus, excoriated papules, and urticaria-like plaques. DATA SOURCES: Clinical, histopathological, and immunofluorescence findings in a patient who developed bullous pemphigoid following narrowband ultraviolet B phototherapy for subacute prurigo. MAIN FINDINGS AND LIMITATIONS: A patient who had been undergoing narrowband ultraviolet B phototherapy for a provisional diagnosis of subacute prurigo subsequently presented with generalized pruritus, which was found to be due to the development of bullous pemphigoid (BP). In cases of subacute prurigo-even when histopathological findings do not support a diagnosis of BP-one should remain vigilant for underlying BP, as UV exposure may trigger its onset. Existing literature supports this observation and our specific case. The limitations of this report include the fact that it is based on a single case and that measurements of BP180 and BP230 antibodies could not be performed. CONCLUSIONS: Patients undergoing phototherapy for pruritic dermatoses should may warrant monitoring for clinical features suggestive of BP. In patients with atypical or treatment-refractory pruritus, direct immunofluorescence and serologic testing for anti-BP180 and anti-BP230 antibodies should be considered.
Authors
- Selami Aykut Temiz (ORCID: https://orcid.org/0000-0003-4878-0045)
- Fahriye Kılınç (ORCID: https://orcid.org/0000-0002-1202-8735)
- Hasan Emre İlgenli (ORCID: https://orcid.org/0009-0002-8051-1232)
- Adnan Semiz
Institutions
- Necmettin Erbakan University (TR)
Publication Details
- Journal
- American Journal of Therapeutics
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1097/mjt.0000000000002262
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00